Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed a reliable way to measure hormones in urine, showing that a baldness treatment doesn't change hormone levels.

Hormonal balance is vital for women's health and performance, but therapies like contraceptives and steroids have both benefits and risks.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.

No significant hormone differences found in postmenopausal women with androgenetic alopecia.

High doses of ethynylestradiol in rats caused growth issues, organ changes, and some tumors, but didn't increase overall tumor rates.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.

Early hormones shape sex-specific differences in rat glands.

Neurosteroids help control dopamine responses in the brain.

Injection contraception has more negative side effects than hormonal pills.

Two peptides, RMYYY and VMYMI, may be effective anti-inflammatory drugs.

Beta-sitosterol has potential health benefits but needs more research to fully understand its effects and improve its use in treatments.

Treprostinil, a drug, can delay wound healing in healthy cells but doesn't affect diabetic foot ulcer cells, suggesting further research could help understand its role in treating these ulcers.

Birth control pills increase the risk of blood clots, especially within the first year and with certain types.

Estetrol may help prevent hair loss and promote hair growth in women.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

GLP-1 receptor agonists can help manage PCOS metabolism but need careful use before conception.

Injected bimatoprost 0.03% solution did not effectively treat female-pattern hair loss.

Hormone levels in hair change during pregnancy, with progesterone increasing significantly compared to non-pregnant women.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Hormone therapy for excessive hair growth is as good with GnRHa as with high-dose CPA, but GnRHa has longer-lasting results.

The PTGER2 gene is highly active in Cashmere goat skin and its activity changes with the hair growth cycle.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Hederagenin shows promise for cancer and inflammation treatment but needs modifications to improve effectiveness.

Low-dose Buserelin effectively reduces hirsutism with minimal side effects.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Some medications can reduce excessive hair growth in women, but more research is needed to find the best treatment combinations.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.